Latest Saturn V Capital Management LLC Stock Portfolio
About Saturn V Capital Management LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Saturn V Capital Management LP reported an equity portfolio of $456 Millions as of 30 Sep, 2025.
The top stock holdings of Saturn V Capital Management LP are , AMLX, JAZZ. The fund has invested 14.9% of it's portfolio in ABIVAX SA and 13.7% of portfolio in AMYLYX PHARMACEUTICALS INC.
The fund managers got completely rid off MOONLAKE IMMUNOTHERAPEUTICS (MLTX), NEUROCRINE BIOSCIENCES INC (NBIX) and ASCENDIS PHARMA A/S stocks. They significantly reduced their stock positions in CELCUITY INC (CELC), NEWAMSTERDAM PHARMA COMPANY (NAMS) and MERUS N V (MRUS). Saturn V Capital Management LP opened new stock positions in PHARVARIS N V (PHVS) and MONOPAR THERAPEUTICS INC (MNPR). The fund showed a lot of confidence in some stocks as they added substantially to DYNE THERAPEUTICS INC (DYN), OCULAR THERAPEUTIX INC (OCUL) and JAZZ PHARMACEUTICALS PLC (JAZZ).
The top stock holdings of Saturn V Capital Management LP are , AMLX, JAZZ. The fund has invested 14.9% of it's portfolio in ABIVAX SA and 13.7% of portfolio in AMYLYX PHARMACEUTICALS INC.
The fund managers got completely rid off MOONLAKE IMMUNOTHERAPEUTICS (MLTX), NEUROCRINE BIOSCIENCES INC (NBIX) and ASCENDIS PHARMA A/S stocks. They significantly reduced their stock positions in CELCUITY INC (CELC), NEWAMSTERDAM PHARMA COMPANY (NAMS) and MERUS N V (MRUS). Saturn V Capital Management LP opened new stock positions in PHARVARIS N V (PHVS) and MONOPAR THERAPEUTICS INC (MNPR). The fund showed a lot of confidence in some stocks as they added substantially to DYNE THERAPEUTICS INC (DYN), OCULAR THERAPEUTIX INC (OCUL) and JAZZ PHARMACEUTICALS PLC (JAZZ).
Saturn V Capital Management LLC Annual Return Estimates Vs S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| pharvaris n v | 22,114,000 |
| monopar therapeutics inc | 12,689,100 |
New stocks bought by Saturn V Capital Management LLC
Additions
| Ticker | % Inc. |
|---|---|
| dyne therapeutics inc | 83.76 |
| ocular therapeutix inc | 58.07 |
| jazz pharmaceuticals plc | 45.26 |
| vaxcyte inc | 44.88 |
| amylyx pharmaceuticals inc | 41.23 |
| abivax sa | 28.72 |
| lenz therapeutics inc | 7.56 |
| xenon pharmaceuticals inc | 7.54 |
Additions to existing portfolio by Saturn V Capital Management LLC
Reductions
| Ticker | % Reduced |
|---|---|
| celcuity inc | -60.03 |
| newamsterdam pharma company | -30.61 |
| merus n v | -17.89 |
| disc medicine inc | -13.94 |
| cogent biosciences inc | -11.86 |
| centessa pharmaceuticals plc | -7.41 |
| cg oncology inc | -1.15 |
Saturn V Capital Management LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| syndax pharmaceuticals inc | -4,687,660 |
| contineum therapeutics inc | -1,267,810 |
| moonlake immunotherapeutics | -13,725,000 |
| replimune group inc | -1,197,640 |
| kalvista pharmaceuticals inc | -709,875 |
| neurocrine biosciences inc | -7,312,770 |
| ascendis pharma a/s | -6,591,770 |
| silence therapeutics plc | -201,475 |
Saturn V Capital Management LLC got rid off the above stocks
Sector Distribution
| Sector | % |
|---|---|
| Healthcare | 66.4 |
| Others | 33.6 |
Market Cap. Distribution
| Category | % |
|---|---|
| UNALLOCATED | 34.5 |
| MID-CAP | 30.6 |
| SMALL-CAP | 18.4 |
| MICRO-CAP | 13.7 |
| NANO-CAP | 2.8 |
Stocks belong to which Index?
| Index | % |
|---|---|
| Others | 58.2 |
| RUSSELL 2000 | 41.8 |
Saturn V Capital Management LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Saturn V Capital Management LLC
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AMLX | amylyx pharmaceuticals inc | 13.72 | 4,604,880 | 62,580,300 | added | 41.23 | ||
| CELC | celcuity inc | 5.13 | 473,828 | 23,407,100 | reduced | -60.03 | ||
| CNTA | centessa pharmaceuticals plc | 3.91 | 734,539 | 17,812,600 | reduced | -7.41 | ||
| COGT | cogent biosciences inc | 6.38 | 2,025,040 | 29,079,600 | reduced | -11.86 | ||
| DYN | dyne therapeutics inc | 7.42 | 2,674,470 | 33,832,000 | added | 83.76 | ||
| JAZZ | jazz pharmaceuticals plc | 8.69 | 300,610 | 39,620,400 | added | 45.26 | ||
| KALV | kalvista pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MLTX | moonlake immunotherapeutics | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MNPR | monopar therapeutics inc | 2.78 | 155,370 | 12,689,100 | new | |||
| MRUS | merus n v | 3.80 | 184,135 | 17,336,300 | reduced | -17.89 | ||
| NAMS | newamsterdam pharma company | 0.96 | 153,147 | 4,355,500 | reduced | -30.61 | ||
| NBIX | neurocrine biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| OCUL | ocular therapeutix inc | 2.95 | 1,151,690 | 13,463,200 | added | 58.07 | ||
| PCVX | vaxcyte inc | 6.23 | 788,441 | 28,399,600 | added | 44.88 | ||
| PHVS | pharvaris n v | 4.85 | 886,332 | 22,114,000 | new | |||
| REPL | replimune group inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SNDX | syndax pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| XENE | xenon pharmaceuticals inc | 4.43 | 503,701 | 20,223,600 | added | 7.54 | ||
| abivax sa | 14.92 | 801,224 | 68,023,900 | added | 28.72 | |||
| cg oncology inc | 5.12 | 579,895 | 23,358,200 | reduced | -1.15 | |||